| NDC Code | 65293-015-03 |
|---|
| Package Description | 3 VIAL, GLASS in 1 CARTON (65293-015-03) > 1 INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION in 1 VIAL, GLASS (65293-015-01) |
|---|
| Product NDC | 65293-015 |
|---|
| Product Type Name | HUMAN PRESCRIPTION DRUG |
|---|
| Proprietary Name | Orbactiv |
|---|
| Non-Proprietary Name | Oritavancin |
|---|
| Dosage Form | INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION |
|---|
| Usage | INTRAVENOUS |
|---|
| Start Marketing Date | 20140901 |
|---|
| End Marketing Date | 20210630 |
|---|
| Marketing Category Name | NDA |
|---|
| Application Number | NDA206334 |
|---|
| Manufacturer | The Medicines Company |
|---|
| Substance Name | ORITAVANCIN |
|---|
| Strength | 400 |
|---|
| Strength Unit | mg/1 |
|---|
| Pharmacy Classes | Lipoglycopeptide Antibacterial [EPC],Lipoglycopeptides [EXT],Cytochrome P450 2C19 Inhibitors [MoA],Cytochrome P450 2C9 Inhibitors [MoA],Cytochrome P450 3A4 Inducers [MoA],Cytochrome P450 2D6 Inducers [MoA] |
|---|